We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+12.41%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$12B
AUM Growth
+$3.27B
(+37%)
Cap. Flow
+$2.75B
Cap. Flow
% of AUM
22.92%
Top 10 Holdings %
Top 10 Hldgs %
16.39%
Holding
1,592
New
371
Increased
506
Reduced
333
Closed
382
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$323M |
| 2 |
Citigroup
C
|
+$240M |
| 3 |
Johnson & Johnson
JNJ
|
+$172M |
| 4 |
Chevron
CVX
|
+$116M |
| 5 |
Cisco
CSCO
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$282M |
| 2 |
Apple
AAPL
|
+$273M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$121M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$118M |
| 5 |
Pfizer
PFE
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.08% |
| 2 | Healthcare | 14.01% |
| 3 | Consumer Discretionary | 13.48% |
| 4 | Communication Services | 10.93% |
| 5 | Financials | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1001
DELISTED
Seagen Inc. Common Stock
SGEN
| $813K | 0.01% |
+4,155
| New | +$696K |
|
1002
Rhythm Pharmaceuticals
RYTM
$8.15B
| $801K | 0.01% |
+36,969
| New | +$848K |
|
1003
Quaker Houghton
KWR
$2.94B
| $797K | 0.01% |
4,433
+849
| +24% | +$163K |
|
1004
Caleres
CAL
$462M
| $796K | 0.01% |
+83,277
| New | +$669K |
|
1005
First Bancorp
FBP
$4.51B
| $793K | 0.01% |
151,998
-49,841
| -25% | -$277K |
|
|
KNL
1006
DELISTED
Knoll, Inc.
KNL
| $786K | 0.01% |
65,161
+9,237
| +17% | +$114K |
|
1007
Purple Innovation
PRPL
$28.7M
| $778K | 0.01% |
+1,252
| New | +$666K |
|
1008
Collegium Pharmaceutical
COLL
$910M
| $775K | 0.01% |
+37,244
| New | +$672K |
|
1009
Rush Enterprises Class A
RUSHA
$9.55B
| $775K | 0.01% |
34,493
+15,078
| +78% | +$320K |
|
1010
Trinity Industries
TRN
$2.32B
| $757K | 0.01% |
38,819
-9,650
| -20% | -$196K |
|
|
TPC
1011
Tutor Perini Cor
TPC
$5.05B
| $755K | 0.01% |
67,870
+14,485
| +27% | +$178K |
|
1012
City Holding Co
CHCO
$2.07B
| $752K | 0.01% |
13,059
-3,395
| -21% | -$212K |
|
1013
MSC Industrial Direct
MSM
$6.7B
| $750K | 0.01% |
11,847
+1,935
| +20% | +$128K |
|
|
AVTA
1014
DELISTED
Avantax, Inc. Common Stock
AVTA
| $747K | 0.01% |
79,329
+62,073
| +360% | +$687K |
|
|
ITCI
1015
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $746K | 0.01% |
+29,078
| New | +$663K |
|
1016
Enviri
NVRI
$579M
| $743K | 0.01% |
53,392
+20,451
| +62% | +$295K |
|
1017
Vishay Intertechnology
VSH
$5.29B
| $743K | 0.01% |
47,732
-27,795
| -37% | -$441K |
|
1018
Weis Markets
WMK
$1.78B
| $724K | 0.01% |
15,084
+4,038
| +37% | +$199K |
|
1019
Heron Therapeutics
HRTX
$63.8M
| $723K | 0.01% |
+48,814
| New | +$762K |
|
1020
Spectrum Brands
SPB
$2.07B
| $719K | 0.01% |
12,572
+4,591
| +58% | +$252K |
|
|
AHRT
1021
AH Realty Trust
AHRT
$506M
| $717K | 0.01% |
77,440
-59,039
| -43% | -$582K |
|
1022
GFL Environmental
GFL
$15B
| $714K | 0.01% |
+33,582
| New | +$676K |
|
1023
Comtech Telecommunications
CMTL
$51.8M
| $712K | 0.01% |
50,862
+34,038
| +202% | +$544K |
|
1024
Regal Rexnord
RRX
$11.5B
| $711K | 0.01% |
+7,577
| New | +$718K |
|
|
AAMI
1025
Acadian Asset Management
AAMI
$3.27B
| $701K | 0.01% |
+54,324
| New | +$716K |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q3 2020 Portfolio in Review
As of Q3 2020, Voloridge Investment Management held 1,592 positions worth $12B, up 37% from $8.75B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Voloridge Investment Management deployed $2.75B of net new capital in Q3 2020, opening 371 new positions and adding to 506 existing holdings. Its largest new stake was Chevron: 1,381,299 shares worth $99.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $282M trimmed.
- Voloridge Investment Management's largest Q3 2020 buy was Chevron: 1,381,299 shares worth $99.5M.
- Voloridge Investment Management added most to AT&T in Q3 2020, an estimated $323M increase.
- Voloridge Investment Management's biggest Q3 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $282M.
- Voloridge Investment Management fully exited Alphabet (Google) Class A in Q3 2020, selling an estimated $121M.
- Voloridge Investment Management's ten largest holdings make up 16% of its $12B portfolio in Q3 2020.
- Voloridge Investment Management opened 371 new positions and closed 382 in Q3 2020.
- Voloridge Investment Management's portfolio value rose 37% quarter-over-quarter to $12B.
Based on Voloridge Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.